Ocular stem cells: a narrative review of current clinical trials
Author:
Corresponding Author:

Konstadinos Sotiropulos. Department of Ophthalmology, 417 Army Shared Fund Hospital, Athens 11521, Greece. konsoti@yahoo.gr

Affiliation:

Clc Number:

Fund Project:

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    Stem cells are undifferentiated cells showcasing a remarkable capacity of self-replenishing and differentiating into mature cells. Their ability to proliferate connotes that a designated stem cell source is capable of generating an unrestricted number of mature cells. The ever-increasing comprehension of position, activity, and function of ocular stem cells has led to rapid progress and incessant improvement of possible procedures and therapies. A narrative review was conducted to summarize the current evidence on clinical trials and respective literature, regarding current evolution in the field of ocular regenerative medicine. We tried to ascertain the safety of experimental and clinical procedures, their effectiveness, and the ethical repercussion of their use.

    Reference
    Related
    Cited by
Get Citation

Konstadinos Sotiropulos, Dimitrios Kourkoutas, Diamantis Almaliotis, et al. Ocular stem cells: a narrative review of current clinical trials. Int J Ophthalmol, 2022,15(9):1529-1537

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
Publication History
  • Received:January 18,2021
  • Revised:June 20,2022
  • Adopted:
  • Online: September 01,2022
  • Published: